Kabra Drugs Board Meeting on Aug 12 to Discuss Q1 Results, Director Resignation

Kabra Drugs Ltd has announced that its Board of Directors will convene on August 12, 2026. The meeting agenda includes the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026, as per SEBI regulations. Additionally, the board will discuss and approve the resignation of Ms. Anand Anitha as a Director. The company has also informed that the trading window for its securities will remain closed until 48 hours after the announcement of the financial results.